Last Updated on October 10, 2024 by The Health Master
New Delhi: The US Food and Drug Administration (USFDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic.
The health regulator said it had received reports of adverse events after patients used compounded versions of semaglutide, the active ingredient in Danish drugmaker Novo Nordisk’s Wegovy and Ozempic.
The USFDA warned patients to refrain from using a compounded drug if an approved drug is available.
Compounded drugs are created by combining, mixing, or altering ingredients to create a medication tailored to the needs of an individual patient.
AThe agency said it does not review compounded versions of these drugs for safety, effectiveness, or quality, adding, it had received reports that compounders might be using salt forms of semaglutide, which are different active ingredients than those used in the approved drugs.
Novo Nordisk’s Ozempic, approved to lower blood sugar levels in adults with type 2 diabetes, saw a supply shortage earlier this year due to high demand, partly driven by prescriptions to non-diabetic patients seeking to lose weight.
The US is expected to account for as much as 90 per cent of weight-loss drug sales due to the number of potential patients and higher pricing than other countries, industry analysts and executives say.
Also read more on USFDA warning letter
7 ways to get relief from Arthritis Pain: Must read
Artificial sweeteners can have serious health effects: WHO
Antibiotic abuse causing drug resistance: Experts
UTI: Dos and Don’ts for managing Urinary Track Infection
Coronavirus: Unusual symptoms – be careful
Personalized vaccines against Cancer & Heart Conditions to be developed
Drug discovered for severe hereditary muscle disease: Researchers
High Uric Acid in Blood: Consume these 5 drinks to control it
Remdesivir not a wonder drug, affects heart: Study
World Tuberculosis Day: Phases of TB and tips by health expert…
USFDA gives approval for Diazepam rectal gel
Chandigarh urges tight monitoring of MRPs in the Pharma Industry
Gas leak at Aurobindo Pharma unit near Hyderabad
China NMPA gives approval for Tildrakizumab injection to treat plaque psoriasis
Delhi High Court grants Centre 6 weeks to finalize Rules for E-Pharmacies
DPCO 2013: Form 2, 4 & 5 amended to add details including GST rate
Line clearance and maintenance in manufacturing: A comprehensive guide
18 held for Sex Determination in Telangana
Medical device packs will have to display key information
Difference between Validation and Calibration in the Pharma Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
